NTRA:NASDAQ
Natera Inc
400,71 $
0,00%
(0,00) 1D
9 հոկ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NTRA...
Mkt. cap
57,76 մլրդ
Avg. vol.
1,65 մլն
Volume
633,00
52-wk high
437,41 $
52-wk low
169,08 $
EPS
-1,37 $
Beta
1,50
Shares outstanding
144,14 մլն
No. of employees
6 հզր
Mkt. cap
57,76 մլրդ
Avg. vol.
1,65 մլն
Volume
633,00
52-wk high
437,41 $
52-wk low
169,08 $
EPS
-1,37 $
Beta
1,50
Shares outstanding
144,14 մլն
No. of employees
6 հզր
News stories
From web sources and news partners
Investing.com Canada
·
1 ժամ առաջ
Form 4 Natera Inc For: 12 October By Investing.com
Benzinga
·
2 ժամ առաջ
Natera Reports Q2 2026 Results: Full Earnings Call Transcript
ad-hoc-news.de
·
3 ժամ առաջ
Natera earns FDA breakthrough designation as Natera stock trades at EUR 360.20
ad-hoc-news.de
·
7 ժամ առաջ
Natera receives FDA breakthrough designation; stock pre-market at EUR 359.20
Profile
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
About Natera Inc
CEOSteven Chapman
Employees6,14 հզր
Founded01 հնվ, 2004 թ.
HeadquartersՕստին, Տեխաս, Միացյալ Նահանգներ
Sector-
Websitenatera.com